Jeremy Chia, Compounder Fund
Jeremy Chia, Compounder Fund
27 January 2022
Companies to watch: What Tesla’s fourth quarter earnings report says about its 2022 outlook
We’re back in the earnings season and if there’s one stock we can’t afford to miss.. It's Elon Musk’s EV giant! Despite stronger-than-expected Q4 results, Tesla's shares plunged more than 5% after the automaker warned supply chain issues could persist throughout 2022. Jeremy Chia, Analyst, Compounder Fund shares some of the highlights coming out of Tesla's earnings call and if they will continue to dominate in this increasingly competitive EV space.
Download the podcast.
Listen to his previous podcasts:
30 December 2020
Bigger Picture: Is it too late to buy vaccine maker stocks?
Jeremy Chia, analyst at Compounder Fund, Galilee Investment Management, shares what the upsides and risks are for investors buying into vaccine makers like Moderna and BioNTech.
Download the podcast.
24 November 2020
Bigger Picture: The good & bad of Tesla
Jeremy Chia, Analyst for Compounder Fund, Galilee Investment Management, discusses what investors should look at before jumping on the market rally behind Tesla, which has gained 500% YTD.
Download the podcast.